CHESTNUT HILL BENEVOLENT ASSOCIATION
1. Target Overview & Investment Thesis
CHESTNUT HILL BENEVOLENT ASSOCIATION is a 20-bed community hospital in NORFOLK, MA with $2.8M in net patient revenue and a -100.0% operating margin. The hospital serves a payer mix of 51.3% Medicare, 0.0% Medicaid, and 48.7% commercial.
Thesis: Turnaround. Our ML models identify $224K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -100.0% to -202.8% (+787bps).
| Net Revenue HCRIS | $2.8M |
| Current EBITDA COMPUTED | $-6.0M |
| Operating Margin COMPUTED | -100.0% |
| Occupancy HCRIS | 17.3% |
| Revenue / Bed COMPUTED | $142K |
| Net-to-Gross HCRIS | 100.0% |
| Distress Probability ML | nan% |
2. Market Context & Competitive Position
MA has 99 Medicare-certified hospitals with a median operating margin of -12.2%. The target's margin of -100.0% places it below the state median. Among 9 size-comparable peers (10-40 beds), the median margin is -16.8%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (10-40), prioritizing same-state peers. 9 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| CHESTNUT HILL BENEVOLENT ASSOC (Target) | MA | 20 | $2.8M | -100.0% |
| DANA-FARBER CANCER INSTITUTE | MA | 30 | $1.88B | -35.1% |
| MARTHAS VINEYARD HOSPITAL | MA | 25 | $121.6M | 3.2% |
| FAIRVIEW HOSPITAL | MA | 24 | $94.5M | 19.8% |
| BAYSTATE WING HOSPITAL & MEDIC | MA | 40 | $91.8M | -16.8% |
| NANTUCKET COTTAGE HOSPITAL | MA | 14 | $65.3M | -25.8% |
| ATHOL MEMORIAL HOSPITAL | MA | 21 | $30.3M | -26.1% |
| WHITTIER HOSPITAL-BRADFORD | MA | 35 | $27.6M | -5.1% |
| CORRIGAN MENTAL HEALTH CENTER | MA | 16 | $nan | nan% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $224K (787bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Denial Rate Reduction | 12.0% | 6.5% | $63K | +221bp | 12mo |
| Net Collection Rate | 93.5% | 97.0% | $60K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $57K | +200bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $35K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $10K | +34bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-6.0M |
| + RCM Uplift | +$224K |
| Pro Forma EBITDA | $-5.8M |
| Current Margin | -100.0% |
| Pro Forma Margin | -202.8% |
| WC Released (1x) | $109K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-9.2M | $-37.3M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-9.2M | $-44.0M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-8.3M | $-46.3M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-8.3M | $-53.0M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-10.1M | $-35.4M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-10.1M | $-42.3M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Low occupancy | At 17.3%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 9 hospitals with 10-40 beds
- Same-state prioritization (n=10)
- Comp margins: P25=-26.0% / P50=-16.8% / P75=-1.0%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.